1 year return (CAGR)
-22.09%
Alzamend Neuro Inc Exchange (NASDAQ, USD)
ALZN
1.94
+0.05 (+2.65%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-81.42%
5 year return (CAGR)
-77.99%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
9.36M
Price/Sales
-
Ent value
10.00M
Price/Book
12.77
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-49.52%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.87 |
| Daily high | 1.94 |
| Daily low | 1.87 |
| Daily Volume | 207K |
| All-time high | 14931.00 |
| 1y analyst estimate | 26.00 |
| Beta | 0.19 |
| EPS (TTM) | -2.63 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALZN | S&P500 | |
| Current price drop from All-time high | -99.99% | -0.56% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 10 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -93.76% | -10.68% |
| Avg time to new high | 441 days | 12 days |
| Max time to new high | 1313 days | 1805 days |
News
